The effect of indomethacin and bone wax on preventing bony bridging after growth plate injury
Acta Orthopaedica et Traumatologica Turcica · 23.10.2026 · 60 (5)
DOI: 10.5152/j.aott.2026.26783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Orthopaedica et Traumatologica Turcica, online erschienen am 23.10.2026. Verfasst von Omar Aljasim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Ege University Faculty of Medicine, İzmir, Türkiye. Hauptthemen laut MEDLINE: Indomethacin, Waxes, Growth Plate, Palmitates. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objective
This study aimed to investigate the efficacy of indomethacin and bone wax, individually and in combination, in preventing bony bridge formation following growth plate injury in a rat model.
Methods
Fifteen skeletally immature male Wistar rats were randomly allocated into 5 groups: an uninjured control, an injured control, an isolated bone wax group, an isolated indomethacin group, and a combination group receiving both bone wax and indomethacin. Following standardized growth plate injuries to the proximal tibia, the respective interventions were applied. On day 28, bone volume fraction (BV/TV%) and bone mineral density (BMD) were calculated using micro-computed tomography (micro-CT). Data distribution was assessed with the Shapiro–Wilk test, and the 5 groups were compared using the Kruskal–Wallis test; values are reported as median (interquartile range [IQR]), with statistical significance set at P < .05.
Results
All treatment groups showed lower BV/TV% and BMD than the control groups, with the combined bone wax and indomethacin group showing the lowest values. Median BV/TV% was 52.49% (IQR = 14.92-70.71) in the combined group vs. 75.63% (IQR = 69.64-77.12) in the injured control group, and median BMD was 14.56 mg/cm3 (IQR = 9.73-26.35) vs. 128.03 mg/cm3 (IQR = 11.93-184.02), respectively. On Kruskal–Wallis testing, however, these differences were not statistically significant (BV/TV% = P = .513; BMD: P = .247).
Conclusion
The combined application of systemic indomethacin and bone wax interposition showed the lowest values for both bone volume fraction and BMD, which may reflect a potential additive effect of attenuating inflammation-driven osteogenesis and physically blocking bony bridging. However, the absence of significant differences underscores the need for further research and clinical trials before their routine clinical application can be recommended. Cite this article as: Aljasim O, Kayikçi K, Vahabi A, Kaya H, Günay H. The effect of indomethacin and bone wax on preventing bony bridging after growth plate injury. Acta Orthop Traumatol Turc.,2026; 60(5), 0783, doi: 10.5152/j.aott.2026.26783.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Ege University Faculty of Medicine, İzmir, Türkiye.
ORCID-Profile: Omar Aljasim, Kayahan Kayıkcı, Arman Vahabi, Hüseyin Kaya, Hüseyin Günay
Zitieren
APA
Aljasim, O., Kayıkcı, K., Vahabi, A., Kaya, H., & Günay, H. (2026). The effect of indomethacin and bone wax on preventing bony bridging after growth plate injury. Acta Orthopaedica et Traumatologica Turcica, 60(5). https://doi.org/10.5152/j.aott.2026.26783
Vancouver
Aljasim O, Kayıkcı K, Vahabi A, Kaya H, Günay H. The effect of indomethacin and bone wax on preventing bony bridging after growth plate injury. Acta Orthopaedica et Traumatologica Turcica. 2026;60(5). doi:10.5152/j.aott.2026.26783
BibTeX
@article{Aljasim2026,
author = {Aljasim, Omar and Kayıkcı, Kayahan and Vahabi, Arman and Kaya, Hüseyin and Günay, Hüseyin},
title = {The effect of indomethacin and bone wax on preventing bony bridging after growth plate injury},
journal = {Acta Orthopaedica et Traumatologica Turcica},
year = {2026},
volume = {60},
number = {5},
doi = {10.5152/j.aott.2026.26783}
}
EUVIMED